检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]复旦大学附属中山医院麻醉科,上海200032 [2]复旦大学附属中山医院心内科,上海200032 [3]复旦大学上海医学院病理学系
出 处:《中华心血管病杂志》2008年第6期551-555,共5页Chinese Journal of Cardiology
基 金:上海市心血管临床医学中心资助项目(ZX02806)
摘 要:目的探讨过表达内皮素1(ET-1)对体外培养的大鼠肺细小动脉平滑肌细胞(RPMC)凋亡的影响及其作用机制。方法采用组织灌注法体外分离和培养原代RPMC,经免疫荧光法和电镜鉴定后,脂质体法瞬时转染ET-1基因,用流式细胞技术检测细胞周期和凋亡,免疫印迹法检测丝/苏氨酸蛋白激酶(Akt/PKB)的磷酸化水平和剪切的半胱天冬酶-3(Caspase-3)的表达。结果成功分离和培养出原代RPMC,实时荧光定量逆转录-聚合酶链反应检测显示,RPMC中ETA受体mRNA表达水平明显高于ETB受体。瞬时转染ET-1基因48h后,流式细胞仪结果显示,与空载相比,RPMC的凋亡明显下降。免疫印迹法检测显示,过表达ET-1后,Akt/PKB的磷酸化水平升高,剪切的Caspase-3的表达水平下降。结论过表达ET-1可能主要通过ETA受体,并经Akt/PKB-Caspase-3信号通路抑制RPMC的凋亡,从而在肺动脉高压的血管重塑过程中发挥重要作用。Objective To investigate the effects of endothehn-1 (ET-1) overexpression on apeptosis of the rat pulmonary arterial microvascular smooth muscle cells ( RPMC ) in vitro. Methods Primary RPMC obtained from the pulmonary artery and lung microvasculature were identified by staining and electron microscope technique. The RPMC was transient transfected with the pMEXneo-ET1 and pCDNAS-FRT-TO-ET1-3'UTR plasmids as well as the empty vector respectively via lipefectamine. Flow cytometry was used to assess the cell cycle and apeptosis of RPMC. Akt and Caspase-3 expressions were detected by Western blot and real time RT-PCR. Results The mRNA of ETA expression was significantly higher than that of ETB receptor in primary RPMC. Flow cytometry analysis revealed significantly reduced apoptosis in ET-1 transfected RPMC compared to that in vehicle transfected RPMC. Overexpression of ET-1 in RPMC also significantly increased the phosphorylation of Akt and reduced the cleaved Caspase-3 expression. Conclusions Overexpression of the ET-1 inhibited RPMC apeptosis and activated Akt/PKB-Caspase-3 signaling pathway, which might be responsible for ET-1 induced the pulmonary microvascular arteries remodeling.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.44